SCAM ALERT: Advisory for Our Partners and Vendors

Cooper has recently learned that its vendors and partners are being solicited by a scammer offering to sell advertising on Cooper’s hospital patient discharge bags. The businesses are receiving calls and emails from an individual claiming to be “Rebecca McCloud” from the “Brand Management and Product Procurement Division.”… Read more.

Mindfulness and Mystery

Please join us for the Mindfulness and Mystery series, a virtual option for engaging in mindfulness exercises led by a “mystery” Cooper team member. Listen to the mindfulness exercise and guess the identity of the mystery team member.… Read more.

January Carebridge Sessions

Carebridge Corporation, Cooper’s employee assistance program, is offering several free, online support sessions through January 2024. Click here for a full list of sessions.… Read more.

Cooper’s Inaugural Mobility Job Fair a Big Success

On December 5, more than 75 team members attended Cooper’s first Mobility Career Fair to learn about the many educational resources available at Cooper, participate in resume writing and resume building services, and to meet with leaders throughout the organization.… Read more.

Annual Team Member Giving Is Here

Join your fellow team members in making a big impact at Cooper and in the communities we serve!

Every day at the Cooper Foundation, we are inspired to see our very own Cooper Team investing in the Cooper mission and the patients and communities we serve.… Read more.

Food Truck Fridays

Food Truck Fridays are continuing to take place on Cooper’s Camden campus.

When:  Every Friday, from 11:30 a.m. to 1:30 p.m. (weather permitting)

Where:  Between Sheridan Pavilion and MD Anderson Cancer Center at Cooper.

To see which vendor is scheduled for each Friday, check the food truck schedule here or on the home page of the Pulse, under Team Member Resources.… Read more.

MD Anderson Cancer Center at Cooper First in the World to Enroll a Patient in a Promising New Clinical Trial for Treatment of Metastatic Melanoma

Researchers at MD Anderson Cancer Center at Cooper are leading the way in new approaches to treating advanced melanoma using tumor infiltrating lymphocyte (TIL) therapy. Earlier this year, MD Anderson at Cooper became the first site in the world to offer and enroll a patient in TILVANCE-301, a new randomized Phase III clinical trial evaluating the efficacy of TIL therapy as a first-line treatment versus pembrolizumab (current standard of immunotherapy care) for advanced melanoma.… Read more.

Update on Johns Hopkins Activity and Mobility Promotion at Cooper

Earlier this year, Cooper team members were participants in mobility advocate training by their peers from Johns Hopkins as part of the #everyBODYmoves campaign. The goal of the program is to break a cycle of deconditioning patients while hospitalized and preventing the occurrence of hospital-acquired conditions and infections.… Read more.

Center for Resuscitation Education and Community Engagement Manager Chosen as Citizen CPR Foundation’s 40 Under 40

Jordan Reeder, Manager of the Center for Resuscitation Education and Community Engagement at Cooper, was selected as one of the honorees of the Citizen CPR Foundation 40 Under 40 Class of 2023.

The Citizen CPR Foundation’s 40 Under 40 recognition program engages, strengthens, and celebrates the future of sudden cardiac arrest training, response, and survival by recognizing 40 outstanding individuals who are under 40 years of age.… Read more.